Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Bachireddy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2012 - 2016- Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2009 - 2012
Stanford University School of MedicineClass of 2009
Certifications & Licensure
TX State Medical License 2021 - 2027
MA State Medical License 2012 - 2022
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Coordinated immune networks in leukemia bone marrow microenvironments distinguish response to cellular therapy.Katie Maurer, Cameron Y Park, Shouvik Mani, Mehdi Borji, Florian Raths
Science Immunology. 2025-01-24 - 1 citationsGPR56 in GVL: marker or mechanism?Audra N Iness, Pavan Bachireddy
Blood. 2024-03-28 - 17 citationsZNF683 marks a CD8T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome.Erin M Parry, Camilla K Lemvigh, Stephanie Deng, Nathan Dangle, Neil Ruthen
Cancer Cell. 2023-10-09
Abstracts/Posters
- Clinical and Immunologic Activity of Ipilimumab Following Decitabine Priming in Post-Allogeneic Transplant and Transplant-Na¥ve Patients with Relapsed or Refractory My...Pavan Bachireddy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- T Cell Determinants of Response and Resistance to PD-1 Blockade in RichterÍs TransformationPavan Bachireddy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
Damon Runyon Cancer Research Foundation Awards $3.6 Million to Top Clinical InvestigatorsJuly 21st, 2023
Grant Support
- Elucidating Human Leukemia and T Cell Interactions within the Tumor MicroenvironmentUNIVERSITY OF TX MD ANDERSON CAN CTR2021–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
